Lupin has launched Sevelamer Hydrochloride tablets (800 mg) in the US market to treat hyperphosphatemia in patients with chronic kidney disease. After receiving approval from the US Food and Drug Administration, the company launched the product (USFDA).
The Russian Direct Investment Fund (RDIF) had billed India as one of Sputnik’s biggest production hubs and markets, though local sales have stagnated at 1.2 million doses out of 1.8 billion doses of various vaccines administered in the country.
The agency has asked Amryt to submit additional data confirming effectiveness of the drug.
Vonjo (pacritinib) belongs to a class of anti-inflammatory drugs known as JAK inhibitors, and it will compete with Incyte Corp’s Jakafi and Bristol Myers’ Inrebic, which were authorised for treating Myelofibrosis in 2011 and 2019, respectively
Abbott has issued a recall for certain Similac baby formula produced in a Michigan facility
Biocon Biologics will aquire Viatris’ biosimilars assets for $3.35 billion
